Nuveen Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.44M | Sell |
313,099
-1,896
| -0.6% | -$14.8K | ﹤0.01% | 2291 |
|
|
2024
Q3 | $3.4M | Sell |
314,995
-449,352
| -59% | -$4.85M | ﹤0.01% | 2171 |
|
|
2024
Q2 | $6.44M | Sell |
764,347
-257,744
| -25% | -$2.17M | ﹤0.01% | 1820 |
|
|
2024
Q1 | $6.87M | Buy |
1,022,091
+777,343
| +318% | +$5.22M | ﹤0.01% | 1813 |
|
|
2023
Q4 | $1.44M | Buy |
244,748
+23,371
| +11% | +$137K | ﹤0.01% | 2569 |
|
|
2023
Q3 | $2.16M | Sell |
221,377
-32,551
| -13% | -$317K | ﹤0.01% | 2270 |
|
|
2023
Q2 | $3.01M | Buy |
253,928
+14,842
| +6% | +$176K | ﹤0.01% | 2156 |
|
|
2023
Q1 | $2.58M | Buy |
239,086
+20,902
| +10% | +$226K | ﹤0.01% | 2236 |
|
|
2022
Q4 | $1.08M | Sell |
218,184
-460,863
| -68% | -$2.29M | ﹤0.01% | 2653 |
|
|
2022
Q3 | $3.37M | Buy |
679,047
+480,816
| +243% | +$2.39M | ﹤0.01% | 2122 |
|
|
2022
Q2 | $983K | Buy |
198,231
+83,583
| +73% | +$414K | ﹤0.01% | 2785 |
|
|
2022
Q1 | $780K | Sell |
114,648
-1,959
| -2% | -$13.3K | ﹤0.01% | 2892 |
|
|
2021
Q4 | $926K | Sell |
116,607
-9,458
| -8% | -$75.1K | ﹤0.01% | 2886 |
|
|
2021
Q3 | $1.13M | Sell |
126,065
-3,785
| -3% | -$34K | ﹤0.01% | 2947 |
|
|
2021
Q2 | $1.05M | Buy |
+129,850
| New | +$1.05M | ﹤0.01% | 2986 |
|